Effect of Increased Levothyroxine Dose on Depressive Mood Effect of Increased Levothyroxine Dose on Depressive Mood
Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
What Happens If Hypothyroidism Is Left Untreated?
Title: What Happens If Hypothyroidism Is Left Untreated?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news
What Causes Hypothyroidism?
Title: What Causes Hypothyroidism?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news
Have I Been Doing This Exam Wrong All This Time? Have I Been Doing This Exam Wrong All This Time?
The Curbsiders share their favorite tips from a jam-packed podcast on hypothyroidism.The Curbsiders (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - August 24, 2020 Category: Universities & Medical Training Tags: Diabetes & Endocrinology Commentary Source Type: news
FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients. The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review. The review was also conducted under Project Orbis, an initiative of the FDA Oncology Center of ...
Source: Roche Media News - July 31, 2020 Category: Pharmaceuticals Source Type: news
FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients. The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review. The review was also conducted under Project Orbis, an initiative of the FDA Oncology Center of ...
Source: Roche Investor Update - July 31, 2020 Category: Pharmaceuticals Source Type: news
Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not justified, the ThyrAMI-2 trialists conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news
Bestselling Author Releases Free Deep Dive Educational Webinar and...
Nationally-known patient advocate and bestselling author Mary Shomon has launched a free educational program on levothyroxine, the most commonly prescribed medication to treat hypothyroidism, and one...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/bestselling_author_releases_free_deep_dive_educational_webinar_and_book_on_levothyroxine_the_most_prescribed_medication_for_hypothyroidism/prweb17267808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 21, 2020 Category: Pharmaceuticals Source Type: news
Contribute to survey on treatment of hypothyroidism in Europe
You are invited to contribute to a series of national surveys of physicians on the management of hypothyroidism in Europe (THESIS; Treatment of Hypothyroidism in Europe by Specialists: an International Survey).The survey aims to gather information from physicians on a number of clinical practice topics relating to hypothyroidism. Whereas such data have been published from the US, there are few reflecting European practices. Twenty three European countries are already taking part.To help with the UK survey, which involves completing an online questionnaire, email Dr Carla Moran atcm682@me...
Source: Society for Endocrinology - July 16, 2020 Category: Endocrinology Source Type: news
Newborn Iodine Status Not Tied to Congenital Hypothyroidism
THURSDAY, July 9, 2020 -- Blood iodine concentrations in newborns do not vary for infants with or without congenital hypothyroidism (CH), although they are higher in cases versus controls in the neonatal intensive care unit (NICU), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2020 Category: Pharmaceuticals Source Type: news
Subclinical Hypothyroidism Appears Common in Women With Miscarriage Subclinical Hypothyroidism Appears Common in Women With Miscarriage
Among women with a history of miscarriage or subfertility, the prevalence of subclinical hypothyroidism is about 20% when using a TSH cutoff of 2.5 mIU/L.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2020 Category: Endocrinology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Increased Hypothyroidism Risk Seen in Young Men With HS Increased Hypothyroidism Risk Seen in Young Men With HS
Hidradenitis suppurativa (HS) increases the risk for hypothyroidism in young men, but not in young women or any older adults, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news
Mild Thyroid Dysfunction Common in Women With Subfertility
WEDNESDAY, June 17, 2020 -- Among women with a history of miscarriage or subfertility trying for a pregnancy, mild subclinical hypothyroidism (SCH) is common, according to a study published online June 17 in the Journal of Clinical Endocrinology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 17, 2020 Category: Pharmaceuticals Source Type: news
L-T4 Before Breakfast vs at Bedtime in Hypothyroidism L-T4 Before Breakfast vs at Bedtime in Hypothyroidism
When is the best time of day to administer L-thyroxine in patients with hypothyroidism? A new meta-analysis compares the effects of different timings.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 16, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients with Hypothyroidism
Conclusion(s): Despite the thyroidal origin of PCT, hypothyroidism did not affect the diagnostic performance of serum PCT levels in predicting bacterial sepsis or septic shock. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news
